Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients With Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-specified Analysis of the RE-DUAL PCI Trial
mediaposted on 2020-06-22, 08:47 authored by José C. Nicolau, Deepak L. Bhatt, Stefan H. Hohnloser, Takeshi Kimura, Gregory Y. H. Lip, Corinna Miede, Matias Nordaby, Jonas Oldgren, Philippe Gabriel Steg, Jurriën M. ten Berg, Lucas C. Godoy, Christopher P. Cannon, The RE-DUAL PCI Steering Committee and Investigators
Article full text
The above video represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.